Zachary Hansen, MD
Family Medicine · Huntington, WVNPI 1902846645
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 94.4% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $9,919, more than ten times the $355 reported in 2019. Among family medicine clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $207.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$10K
- Braeburn Inc.$200
- Lilly USA, LLC$79
- Merck$41
- Strongbridge US Inc.$40
- Alkermes, Inc.$39
- plus $180 from 9 others
What the payments were for
- Consulting fees$4,41643%
- Speaking & faculty fees$2,77627%
- Travel & lodging$2,29922%
- Food & beverage$8678%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 24 | $9,779 |
| Braeburn Inc. | 1 | $200 |
| Lilly USA, LLC | 6 | $79 |
| Merck | 3 | $41 |
| Strongbridge US Inc. | 2 | $40 |
| Alkermes, Inc. | 2 | $39 |
| AbbVie | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Pfizer | 2 | $26 |
| Gilead | 1 | $21 |
| GSK | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Novo Nordisk | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,359 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 95 | $30,511 |
| OzempicSemaglutide | 19 | $28,097 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 226 | $17,858 |
| Spiriva HandihalerTiotropium Bromide | 13 | $16,944 |
| JanuviaSitagliptin Phosphate | 18 | $15,706 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $11,793 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $9,511 |
| OxycontinOxycodone Hcl | 12 | $9,445 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $7,056 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $6,362 |
| Buprenorphine | 21 | $5,788 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 196 | $5,216 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $2,851 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,623 |
| Gabapentin | 177 | $2,338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $9,779 | $30,51195 claims |
| Novo NordiskOzempic | $11 | $28,09719 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $14 | $21,30325 claims |
| MerckJanuvia | $41 | $15,70618 claims |
| AstraZenecaSymbicort | $13 | $7,05614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Huntington
- John CornellHuntington$68K
- Myron LewisHuntington$17K
- Terrence TriplettHuntington$15K
- Russell SnyderHuntington$15K
- Ahmed AbdelgaberHuntington$14K
- Chandos TackettHuntington$12K
- Robert TurnerHuntington$10K
- Gregory CaricoHuntington$9K
- Julie DetempleSouth Charleston$129K
- Isha WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.